These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Alterations in serum glucose and hepatic glycogen concentrations during octanoate administration in rabbits. Trice JE; Trauner DA Pediatr Neurol; 1985; 1(5):294-7. PubMed ID: 3880415 [TBL] [Abstract][Full Text] [Related]
26. Monitoring and management of increased intracranial pressure in Reye syndrome: results in 29 children. Shaywitz BA; Rothstein P; Venes JL Pediatrics; 1980 Aug; 66(2):198-204. PubMed ID: 6773021 [No Abstract] [Full Text] [Related]
27. Effect of increasing carbon chain length on organic acid transport by the choroid plexus: a potential factor in Reye's syndrome. Kim CS; O'Tuama LA; Mann JD; Roe CR Brain Res; 1983 Jan; 259(2):340-3. PubMed ID: 6402269 [TBL] [Abstract][Full Text] [Related]
29. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome. Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury--Results From an Automated Data Collection System Time-Synched to Drug Administration. Shein SL; Ferguson NM; Kochanek PM; Bayir H; Clark RS; Fink EL; Tyler-Kabara EC; Wisniewski SR; Tian Y; Balasubramani GK; Bell MJ Pediatr Crit Care Med; 2016 Mar; 17(3):236-45. PubMed ID: 26673840 [TBL] [Abstract][Full Text] [Related]
31. Effect of chain length of short-chain fatty acids on their effect on intracranial pressure in rabbits. Trauner DA; Adams H J Neurol Neurosurg Psychiatry; 1982 May; 45(5):428-30. PubMed ID: 6806449 [TBL] [Abstract][Full Text] [Related]
32. Metabolic response to hypertonic glucose administration in Reye syndrome. Haymond MW; Karl IE; Keating JP; DeVivo DC Ann Neurol; 1978 Mar; 3(3):207-15. PubMed ID: 666261 [TBL] [Abstract][Full Text] [Related]
33. Intracranial pressure monitoring in Reye-Johnson syndrome. Mickell J; Cook DR; Reigel DH; Painter MJ; Safar P Crit Care Med; 1976; 4(1):1-7. PubMed ID: 1253611 [No Abstract] [Full Text] [Related]
34. REYE (RAY'S) SYNDROME: A PROBLEM EVERYONE SHOULD REMEMBER. Chornomydz I; Boyarchuk O; Chornomydz A Georgian Med News; 2017 Nov; (272):110-118. PubMed ID: 29227269 [TBL] [Abstract][Full Text] [Related]
36. Critical care and anesthetic management of Reye's syndrome. Hubbert CH South Med J; 1979 Jun; 72(6):684-6. PubMed ID: 451652 [TBL] [Abstract][Full Text] [Related]
37. Drug therapy for Reye's syndrome. Mutchie KD; Burckart GJ Am J Hosp Pharm; 1979 Jun; 36(6):767-73. PubMed ID: 463892 [TBL] [Abstract][Full Text] [Related]
38. Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Ulrich RG; Bacon JA; Brass EP; Cramer CT; Petrella DK; Sun EL Chem Biol Interact; 2001 May; 134(3):251-70. PubMed ID: 11336974 [TBL] [Abstract][Full Text] [Related]
39. Acute dimethyl sulfoxide therapy in experimental brain edema: Part I. Effects on intracranial pressure, blood pressure, central venous pressure, and brain water and electrolyte content. Camp PE; James HE; Werner R Neurosurgery; 1981 Jul; 9(1):28-33. PubMed ID: 7279169 [TBL] [Abstract][Full Text] [Related]
40. Brain resuscitation in metabolic-toxic infectious encephalopathy. Safar P Crit Care Med; 1978; 6(1):68-70. PubMed ID: 639535 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]